Loading...

Single-agent and combination biologics in acute myeloid leukemia

Acute myeloid leukemia (AML) is a heterogeneous malignancy characterized by recurrent genetic, epigenetic, and metabolic abnormalities. As a result of our increasing knowledge of the underlying biology of AML leading to rational drug development, several new targeted agents have been recently added...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Hematology Am Soc Hematol Educ Program
Main Authors: Richard-Carpentier, Guillaume, DiNardo, Courtney D.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Hematology 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6913489/
https://ncbi.nlm.nih.gov/pubmed/31808888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019000059
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!